三乙醇胺治疗乳腺癌改良术后胸壁放射性皮肤损伤的临床观察

Clinical observation of trolamine in the treatment of radiation-induced skin toxicity on the breast in breast cancinoma patients after modified mastectomy

为了观察三乙醇胺治疗乳腺癌改良术后胸壁放射性皮肤损伤的临床疗效。将 2 6例乳腺癌改良术后胸壁放疗患者予三乙醇胺涂用。放疗期间胸壁皮肤放射性损伤发生率Ⅰ级为 5 7 7% ;Ⅱ级为 3 0 8% ;Ⅲ级为 11 5 %。初步研究结果提示 ,三乙醇胺能有效降低乳腺癌改良术后胸壁放射性皮肤损伤的程度 ,促进损伤修复 ,且无明显毒副反应 。

The objective is to observe clinical effects of trolamine in the treatment of radiation-induced skin toxicity on the breast in breast carcinoma patients after modified mastectomy. Trolamine is usesd on the breast skin of twenty-six breast carcinoma patients who were in the radiationtherapy after modified mastectomy. The incidences of the toxicities at Ⅰ degree were 57.7%;at Ⅱ degree were 30.8%;at Ⅲ degree were 11.5%.The results suggested that trolamine can decrease the degree of the radiation-induced skin toxicities on the breast in breast carcinoma patients after modified mastectomy.Trolamine is safe for human and has not toxic reaction.